Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Kewaunee Scientific (KEQU) over the last 14 years, with Q4 2025 value amounting to $561000.0.

  • Kewaunee Scientific's Share-based Compensation rose 5040.21% to $561000.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $1.8 million, marking a year-over-year increase of 4146.72%. This contributed to the annual value of $1.4 million for FY2025, which is 4017.51% up from last year.
  • Kewaunee Scientific's Share-based Compensation amounted to $561000.0 in Q4 2025, which was up 5040.21% from $521000.0 recorded in Q3 2025.
  • Kewaunee Scientific's Share-based Compensation's 5-year high stood at $561000.0 during Q4 2025, with a 5-year trough of $129000.0 in Q1 2021.
  • For the 5-year period, Kewaunee Scientific's Share-based Compensation averaged around $277200.0, with its median value being $241000.0 (2023).
  • Its Share-based Compensation has fluctuated over the past 5 years, first skyrocketed by 239000.0% in 2021, then crashed by 2719.03% in 2024.
  • Over the past 5 years, Kewaunee Scientific's Share-based Compensation (Quarter) stood at $150000.0 in 2021, then surged by 30.67% to $196000.0 in 2022, then increased by 22.96% to $241000.0 in 2023, then skyrocketed by 54.77% to $373000.0 in 2024, then surged by 50.4% to $561000.0 in 2025.
  • Its Share-based Compensation was $561000.0 in Q4 2025, compared to $521000.0 in Q3 2025 and $370000.0 in Q2 2025.